Jane H. Buckner

17.4k total citations · 5 hit papers
188 papers, 11.8k citations indexed

About

Jane H. Buckner is a scholar working on Immunology, Rheumatology and Genetics. According to data from OpenAlex, Jane H. Buckner has authored 188 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Immunology, 53 papers in Rheumatology and 51 papers in Genetics. Recurrent topics in Jane H. Buckner's work include T-cell and B-cell Immunology (78 papers), Immune Cell Function and Interaction (72 papers) and Diabetes and associated disorders (48 papers). Jane H. Buckner is often cited by papers focused on T-cell and B-cell Immunology (78 papers), Immune Cell Function and Interaction (72 papers) and Diabetes and associated disorders (48 papers). Jane H. Buckner collaborates with scholars based in United States, Sweden and United Kingdom. Jane H. Buckner's co-authors include Steven F. Ziegler, S. Alice Long, Mindi Walker, Mary Rieck, Gerald T. Nepom, Carla J. Greenbaum, Vivian H. Gersuk, Angèle Bénard, Deborah J. Kasprowicz and Jeffrey A. Bluestone and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Jane H. Buckner

183 papers receiving 11.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

2003 1.0k citations Mindi Walker, Deborah J. Kasprowicz et al. Journal of Clinical Investigation profile →
Type 1 diabetes immunotherapy using polyclonal regulatory T cells

2015 810 citations Jane H. Buckner, Kevan C. Herold et al. Science Translational Medicine profile →
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases

2010 607 citations Jane H. Buckner profile →
Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction

2018 257 citations V. Michael Holers, M. Kristen Demoruelle et al. Nature Reviews Rheumatology profile →
Immunotherapy: Building a bridge to a cure for type 1 diabetes

2021 137 citations Jane H. Buckner, Kevan C. Herold et al. profile →

Peers

Countries citing papers authored by Jane H. Buckner

Since Specialization

Citations

This map shows the geographic impact of Jane H. Buckner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane H. Buckner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane H. Buckner more than expected).

Fields of papers citing papers by Jane H. Buckner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane H. Buckner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane H. Buckner. The network helps show where Jane H. Buckner may publish in the future.

Co-authorship network of co-authors of Jane H. Buckner

This figure shows the co-authorship network connecting the top 25 collaborators of Jane H. Buckner. A scholar is included among the top collaborators of Jane H. Buckner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane H. Buckner. Jane H. Buckner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic and epigenetic screens in primary human T cells link candidate causal autoimmune variants to T cell networks 2025 ·Nature Genetics ·(unknown), (unknown), (unknown), (unknown), Arpit Mishra, Stephan Pribitzer, (unknown), Harshpreet Chandok, Florence M. Chardon, Troy A. McDiarmid, Hannah A. DeBerg, Jane H. Buckner, Jay Shendure, Carl G. de Boer, Michael H. Guo, Ryan Tewhey, John Ray	0
2	Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy 2024 ·Journal of Autoimmunity ·(unknown), Soo Jung Yang, Ethan McClain, Alex Hu, (unknown), (unknown), Janice Chen, (unknown), Akhilesh K. Singh, Eddie A. James, (unknown), Asma Siddique, David J. Rawlings, (unknown), Karen Cerosaletti, Jane H. Buckner	5
3	Lupus IgA1 autoantibodies synergize with IgG to enhance plasmacytoid dendritic cell responses to RNA-containing immune complexes 2024 ·Science Translational Medicine ·Hayley R. Waterman, Matthew J. Dufort, (unknown), Minjian Ni, Lucy Z. Li, Chengsong Zhu, Prithvi Raj, Kelly D. Smith, Jane H. Buckner, Jessica A. Hamerman	9
4	Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis 2024 ·Nature Reviews Rheumatology ·V. Michael Holers, (unknown), Jane H. Buckner, Eddie A. James, Gary S. Firestein, William H. Robinson, Allen C. Steere, Fan Zhang, Jill M. Norris, Kristine A. Kuhn, Kevin D. Deane	16
5	Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune-modifying therapies 2023 ·JCI Insight ·(unknown), Lauren B. Rodda, Chihiro Morishima, Mark H. Wener, Yevgeniy Yuzefpolskiy, Estelle Bettelli, Jane H. Buckner, Cate Speake, Marion Pepper, Daniel Campbell	3
6	Immune‐related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity 2023 ·Immunological Reviews ·Namrata Singh, Anne M. Hocking, Jane H. Buckner	27
7	Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis 2023 ·Nature Communications ·Jae‐Seung Moon, Shady Younis, Nitya S. Ramadoss, Radhika Iyer, Khushboo Sheth, Orr Sharpe, Navin Rao, Stéphane Bécart, Julie Carman, Eddie A. James, Jane H. Buckner, Kevin D. Deane, V. Michael Holers, Susan M. Goodman, Laura T. Donlin, Mark M. Davis, William H. Robinson	54
8	Genetic basis of defects in immune tolerance underlying the development of autoimmunity 2022 ·Frontiers in Immunology ·Anne M. Hocking, Jane H. Buckner	16
9	Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum 2022 ·Science Translational Medicine ·(unknown), Adam R. Lefferts, Michael R. Clay, Alexander Hsu, Jennifer Seifert, Marie L. Feser, Cliff Rims, Michelle S. Bloom, Elizabeth A. Bemis, Sucai Liu, (unknown), Daniel N. Frank, M. Kristen Demoruelle, Kevin D. Deane, Eddie A. James, Jane H. Buckner, William H. Robinson, V. Michael Holers, Kristine A. Kuhn	101
10	The dynamic epigenetic regulation of the inactive X chromosome in healthy human B cells is dysregulated in lupus patients 2021 ·Proceedings of the National Academy of Sciences ·Sarah Pyfrom, Bam Paneru, James J. Knox, Michael P. Cancro, (unknown), Jane H. Buckner, Montserrat C. Anguera	70
11	Evaluating associations of joint swelling, joint stiffness and joint pain with physical activity in first-degree relatives of patients with rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA), a prospective cohort study 2021 ·BMJ Open ·Jan M. Hughes‐Austin, Joachim H. Ix, Samuel R. Ward, Michael H. Weisman, James R. O’Dell, Ted R. Mikuls, Jane H. Buckner, Peter K. Gregersen, Richard M. Keating, M. Kristen Demoruelle, Kevin D. Deane, V. Michael Holers, Jill M. Norris	4
12	The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity 2021 ·Journal of Clinical Investigation ·Hamid Bolouri, Cate Speake, David Skibinski, S. Alice Long, Anne M. Hocking, Daniel Campbell, Jessica A. Hamerman, Uma Malhotra, Jane H. Buckner	22
13	Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis 2021 ·JCI Insight ·Jing Song, Anja Schwenzer, Alicia Wong, (unknown), Cliff Rims, (unknown), (unknown), Christina Gerstner, (unknown), Kim S. Midwood, Vivianne Malmström, Eddie A. James, Jane H. Buckner	37
14	Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity 2019 ·The Journal of Immunology ·Panos Stathopoulos, (unknown), Patrick Waters, Sarosh R. Irani, Miriam L. Fichtner, (unknown), Joel M. Guthridge, Jennifer Seifert, Richard J. Nowak, Jane H. Buckner, V. Michael Holers, Judith A. James, David A. Hafler, Kevin C. O’Connor	21
15	Anticyclic Citrullinated Peptide Antibodies 3.1 and Anti-CCP-IgA Are Associated with Increasing Age in Individuals Without Rheumatoid Arthritis 2019 ·The Journal of Rheumatology ·(unknown), Kristen J. Polinski, Ted R. Mikuls, (unknown), (unknown), (unknown), Michael Mähler, Michael H. Weisman, James R. O’Dell, Richard M. Keating, Jane H. Buckner, Peter K. Gregersen, Jill M. Norris, V. Michael Holers, Kevin D. Deane, M. Kristen Demoruelle	6
16	Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes—The TrialNet Experience 2018 ·Diabetes ·Carla J. Greenbaum, Cate Speake, Jeffrey P. Krischer, Jane H. Buckner, Peter A. Gottlieb, Desmond Schatz, Kevan C. Herold, Mark A. Atkinson	34
17	Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis 2017 ·Science Immunology ·Carmelo Carmona‐Rivera, Philip M. Carlucci, Erica Moore, Nithya Lingampalli, Hannes Uchtenhagen, Eddie A. James, Yudong Liu, Kevin L. Bicker, Heidi Wähämaa, Victoria Hoffmann, Anca I. Catrina, Paul R. Thompson, Jane H. Buckner, William H. Robinson, David A. Fox, Mariana J. Kaplan	239
18	The Autoimmune Risk Variant PTPN22 C1858T Alters B Cell Tolerance at Discrete Checkpoints and Differentially Shapes the Naive Repertoire 2017 ·The Journal of Immunology ·Genita Metzler, Xuezhi Dai, Christopher D. Thouvenel, Socheath Khim, Tania Habib, Jane H. Buckner, David J. Rawlings	19
19	In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive T _regs Involves IL-6–Mediated Signaling 2013 ·Science Translational Medicine ·Anya Schneider, S. Alice Long, Karen Cerosaletti, Chester Ni, Peter L. Samuels, Mariko Kita, Jane H. Buckner	130
20	Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells breakdown → 2003 ·Journal of Clinical Investigation ·Mindi Walker, Deborah J. Kasprowicz, Vivian H. Gersuk, Angèle Bénard, (unknown), Jane H. Buckner, Steven F. Ziegler	1007

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact